OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - CVS HEALTH Share Price

Certificat

DE000SW9WJG4

Market Closed - Boerse Frankfurt Warrants 20:45:09 27/06/2024 BST
1.16 EUR +23.40% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - CVS HEALTH
Current month+14.29%
1 month-9.09%
Date Price Change
27/06/24 1.2 +27.66%
26/06/24 0.94 +3.30%
25/06/24 0.91 +10.98%
24/06/24 0.82 -6.82%
21/06/24 0.88 -1.12%

Real-time Boerse Frankfurt Warrants

Last update June 27, 2024 at 08:45 pm

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellPUT
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SW9WJG
ISINDE000SW9WJG4
Date issued 03/05/2024
Strike 70.64 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.36
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.61
Lowest since issue 0.8

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
58.36 USD
Average target price
69.1 USD
Spread / Average Target
+18.40%
Consensus